Lusay, Anita P.
HRN: 26-57-29 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/24/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/24/2025
01/31/2025
IV
1.5g
Q8
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes